Bioengineering & Translational Medicine is a peer-reviewed english-language open-access journal published by Wiley in United States, operating under an open-access model since 2016. The journal covers Chemical technology: Chemical engineering, Therapeutics. Pharmacology, and Chemical technology: Biotechnology.
Authors are required to pay an article processing charge to publish in Bioengineering & Translational Medicine; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
Keywords
drug delivery, tissue engineering, synthetic biology, biosensors, biomolecular engineering, immunotherapy
At a glance
- Publisher
- Wiley
- Country
- United States
- Primary language
- English
- License
- CC BY
- Peer review
- Peer review, Anonymous peer review
- OA since
- 2016
ISSN
- electronic
- 2380-6761
Frequently asked questions
Is Bioengineering & Translational Medicine peer-reviewed?
Yes — Bioengineering & Translational Medicine operates a Peer review, Anonymous peer review review process.
Does Bioengineering & Translational Medicine charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Bioengineering & Translational Medicine publish?
Bioengineering & Translational Medicine publishes research in Chemical technology: Chemical engineering, Therapeutics. Pharmacology, and Chemical technology: Biotechnology.
What languages does Bioengineering & Translational Medicine accept?
Bioengineering & Translational Medicine accepts manuscripts in English.
What is the ISSN of Bioengineering & Translational Medicine?
ISSN:
2380-6761 (electronic).How do I submit a manuscript to Bioengineering & Translational Medicine?
Submit through the journal's official portal: visit submission page →